Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Transdermal Drug Delivery Systems Market: By Application, By Technology and Region Forecast 2020-2031
Transdermal Drug Delivery Systems Market size was valued at US$ 74.1 billion in 2024 and is expected to reach US$ 162.7 billion by 2031, growing at a significant CAGR of 11.9% from 2025-2031. The market is the self-contained, discrete dosage applied in the form of patches to the intact skin and delivers medication through the controlled rate. The main aim of transdermal patches is to deliver the medication into the systemic circulation at controlled rates to minimize the intra and interpatient variation. Transdermal drug delivery methods enable systemic drug circulation and maintain clinically efficacious concentrations at a predefined pace with minimum inter-and intrapatient variation by delivering the drug through the skin. It's a medicated adhesive bandage that sticks to the skin and releases the medicine into the bloodstream. It lessens the strain on the digestive tract and liver that comes with taking pills orally. It increases therapeutic efficacy and safety, keeps drug levels stable in the blood, and solves the drawbacks of traditional oral dosage forms and parenteral formulations.
The global market provides a detailed overview and which can be segmented by technology, application, and region. By technology, the market has been segmented into electric current, electroporation, radio frequency, thermal, ultrasound, and others. By technology, the electroporation segment is expected to have a significant growth rate over the forecasted period due to the increasing high for electroporation technology in the field of transdermal drug delivery globally. Based on application, the segment has been segregated into cardiovascular, contraception, pain management / neurological disorders, smoking cessation, and others. By application, the pain management segment is expected to account for the majority of the share of the market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.
Study Period
2025-2031Base Year
2024CAGR
11.9%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
An increase in the global population has significantly increased the demand for geriatric medicines. Also, transdermal drug delivery systems help deliver drugs in a controlled manner, thereby increasing the effectiveness of geriatric medicines. Apart from this, the number of patients suffering from chronic diseases, such as heart disease, diabetes, and arthritis has steadily increased these days, and also these chronic diseases are a leading cause of disability and death globally.
Additionally, rising awareness among patients, regarding the use of enormous medicines has also increased. These factors have impacted positively the global transdermal drug delivery systems market growth.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 74.1 billion |
Market Size in 2031 |
US$ 162.7 billion |
Market CAGR |
11.9% |
By Application |
|
By Technology |
|
By Region |
|
Download Free Sample Report
Transdermal drug delivery systems market size was valued at US$ 74.1 billion in 2024 and is expected to reach US$ 162.7 billion by 2031, growing at a significant CAGR of 11.9%.
The major factors driving the market growth are the increases in the demand for self-administration of drugs for the long-term treatment of diverse disorders.
Business expansion is a key growth strategy opted by industry players of transdermal drug delivery system.
1. Executive Summary |
2. Global Transdermal Drug Delivery Systems Market Introduction |
2.1.Global Transdermal Drug Delivery Systems Market - Taxonomy |
2.2.Global Transdermal Drug Delivery Systems Market - Definitions |
2.2.1.Application |
2.2.2.Technology |
2.2.3.Region |
3. Global Transdermal Drug Delivery Systems Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Transdermal Drug Delivery Systems Market Analysis, 2020-2024 and Forecast 2025-2031 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Transdermal Drug Delivery Systems Market By Application, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
5.1. Cardiovascular |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Contraception |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Pain Management / Neurological Disorders |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Smoking Cessation |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Transdermal Drug Delivery Systems Market By Technology, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
6.1. Electric Current |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Electroporation |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Radio Frequency |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Thermal |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Ultrasound |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Others |
6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7. Global Transdermal Drug Delivery Systems Market By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Transdermal Drug Delivery Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
8.1. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Cardiovascular |
8.1.2.Contraception |
8.1.3.Pain Management / Neurological Disorders |
8.1.4.Smoking Cessation |
8.1.5.Others |
8.2. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Electric Current |
8.2.2.Electroporation |
8.2.3.Radio Frequency |
8.2.4.Thermal |
8.2.5.Ultrasound |
8.2.6.Others |
8.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9. Europe Transdermal Drug Delivery Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
9.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Cardiovascular |
9.1.2.Contraception |
9.1.3.Pain Management / Neurological Disorders |
9.1.4.Smoking Cessation |
9.1.5.Others |
9.2. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Electric Current |
9.2.2.Electroporation |
9.2.3.Radio Frequency |
9.2.4.Thermal |
9.2.5.Ultrasound |
9.2.6.Others |
9.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10. Asia Pacific (APAC) Transdermal Drug Delivery Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
10.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cardiovascular |
10.1.2.Contraception |
10.1.3.Pain Management / Neurological Disorders |
10.1.4.Smoking Cessation |
10.1.5.Others |
10.2. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Electric Current |
10.2.2.Electroporation |
10.2.3.Radio Frequency |
10.2.4.Thermal |
10.2.5.Ultrasound |
10.2.6.Others |
10.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11. Middle East and Africa (MEA) Transdermal Drug Delivery Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cardiovascular |
11.1.2.Contraception |
11.1.3.Pain Management / Neurological Disorders |
11.1.4.Smoking Cessation |
11.1.5.Others |
11.2. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Electric Current |
11.2.2.Electroporation |
11.2.3.Radio Frequency |
11.2.4.Thermal |
11.2.5.Ultrasound |
11.2.6.Others |
11.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12. Latin America Transdermal Drug Delivery Systems Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
12.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cardiovascular |
12.1.2.Contraception |
12.1.3.Pain Management / Neurological Disorders |
12.1.4.Smoking Cessation |
12.1.5.Others |
12.2. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Electric Current |
12.2.2.Electroporation |
12.2.3.Radio Frequency |
12.2.4.Thermal |
12.2.5.Ultrasound |
12.2.6.Others |
12.3. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1. Novartis AG (Switzerland) |
13.2.2. Boehringer Ingelheim GmbH (Germany) |
13.2.3. Generex Biotechnology Corp. (Canada) |
13.2.4. Echo Therapeutics, Inc. (U.S.) |
13.2.5. Crescita Therapeutics Inc (Canada) |
13.2.6. MedPharm (U.K.) |
13.2.7. Pantec Biosolutions AG (Liechtenstein) |
13.2.8. Transdermal Corp. (U.S.) |
13.2.9. Noven Pharmaceuticals, Inc. (U.S.) |
13.2.10. Actelion Pharmaceuticals Ltd (Switzerland) |
13.2.11. Johnson & Johnson Limited (U.S.) |
13.2.12. 3M Pharmaceuticals Inc. (U.S.) |
13.2.13. Mylan Pharmaceuticals Inc. (U.S.) |
13.2.14. GlaxoSmithKline plc (U.K.) |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players